Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13210189 | 1.00 | MCL1 (0.31) | MCL1 | |
| SCHEMBL3022928 | 1.00 | MCL1 (0.31) | MCL1 | |
| SCHEMBL13210191 | 1.00 | MCL1 (0.31) | MCL1 | |
| SCHEMBL13210190 | 1.00 | MCL1 (0.31) | MCL1 | |
| SCHEMBL3077147 | 0.84 | KMT2A (0.31) | MCL1 | |
| SCHEMBL16516011 | 0.84 | KMT2A (0.31) | MCL1 | |
| SCHEMBL3077150 | 0.84 | KMT2A (0.31) | MCL1 | |
| SCHEMBL3642589 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL15201235 | 0.80 | ALDH1A1 (0.33) | — | |
| SCHEMBL60485 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2814809-B1 | NOVEL PROCESS FOR THE MANUFACTURE OF METHYL LIMONITRILE | DSM IP ASSETS BV (NL) | 2017-03-22 | — | — | EP | claimed |
| EP-2628723-B1 | Novel process for the manufacture of methyl limonitrile | DSM IP ASSETS BV (NL) | 2014-09-10 | — | — | EP | claimed |
| EP-2173704-B1 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2013-09-11 | — | — | EP | claimed |
| US-20100204083-A1 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2010-08-12 | — | — | US | claimed |
| EP-2173704-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2010-04-14 | — | — | EP | claimed |
| WO-2009052643-A1 | ANTI-MALODOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2009-04-30 | — | — | WO | claimed |
| WO-2009013199-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2009-01-29 | — | — | WO | claimed |
| EP-3036216-B1 | PROCESS FOR THE MANUFACTURE OF HYDROGENATED NITRILES | DSM IP ASSETS BV (NL) | 2019-06-12 | — | — | EP | disclosed |
| EP-2814809-B1 | NOVEL PROCESS FOR THE MANUFACTURE OF METHYL LIMONITRILE | DSM IP ASSETS BV (NL) | 2017-03-22 | — | — | EP | disclosed |
| EP-2814809-B1 | NOVEL PROCESS FOR THE MANUFACTURE OF METHYL LIMONITRILE | DSM IP ASSETS BV (NL) | 2017-03-22 | — | — | EP | disclosed |
| US-9458096-B2 | Process for the manufacture of methyl limonitrile | DSM IP ASSETS B.V. (NL) | 2016-10-04 | — | — | US | disclosed |
| US-9458096-B2 | Process for the manufacture of methyl limonitrile | DSM IP ASSETS B.V. (NL) | 2016-10-04 | — | — | US | disclosed |
| US-9340750-B2 | Process for the manufacture of methyl limonitrile | DSM IP ASSETS B.V. (NL) | 2016-05-17 | — | — | US | disclosed |
| EP-2173704-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2010-04-14 | — | — | EP | disclosed |
| EP-2173704-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2010-04-14 | — | — | EP | disclosed |
| WO-2009052643-A1 | ANTI-MALODOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2009-04-30 | — | — | WO | disclosed |
| WO-2009013199-A3 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009013199-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2009-01-29 | — | — | WO | disclosed |
| WO-2009013199-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2009-01-29 | — | — | WO | disclosed |
| WO-2009013199-A2 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | BASF SE (DE) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204083-A1 | PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE | CYP51A1, ESD, CYP3A4 | MCL1 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.